Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Quilici

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Archives of Cardiovascular Diseases|December 6, 2008
Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromesLaurent Bali, Thomas Cuisset, Roch Giorgi, et al.
The American Journal of Cardiology|April 9, 2008
Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndromeCorinne Frere, Thomas Cuisset, Pierre-Emmanuel Morange, et al.
Thrombosis and Haemostasis|February 1, 2007
Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndromeThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
American Heart Journal|September 18, 2012
Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomesThomas Cuisset, Jacques Quilici, Marie Loosveld, et al.
Obesity (Silver Spring, Md.)|October 8, 2011
Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot studyBénédicte Gaborit, Frank Kober, Alexis Jacquier, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs)Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, et al.
International Journal of Cardiology|October 23, 2012
Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapyThomas Cuisset, Bénédicte Gaborit, Noémie Dubois, et al.
The American Journal of Cardiology|October 9, 2012
Prasugrel monitoring and bleeding in real world patientsGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
JACC. Cardiovascular Interventions|December 22, 2012
CYP2C19*2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndromeThomas Cuisset, Marie Loosveld, Pierre Emmanuel Morange, et al.
The American Journal of Cardiology|November 5, 2013
Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stentingMathieu Pankert, Jacques Quilici, Anderson Diendonné Loundou, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Archives of Cardiovascular Diseases|December 6, 2008
Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromesLaurent Bali, Thomas Cuisset, Roch Giorgi, et al.
The American Journal of Cardiology|April 9, 2008
Effect of cytochrome p450 polymorphisms on platelet reactivity after treatment with clopidogrel in acute coronary syndromeCorinne Frere, Thomas Cuisset, Pierre-Emmanuel Morange, et al.
Thrombosis and Haemostasis|February 1, 2007
Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndromeThomas Cuisset, Corinne Frere, Jacques Quilici, et al.
American Heart Journal|September 18, 2012
Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomesThomas Cuisset, Jacques Quilici, Marie Loosveld, et al.
Obesity (Silver Spring, Md.)|October 8, 2011
Epicardial fat volume is associated with coronary microvascular response in healthy subjects: a pilot studyBénédicte Gaborit, Frank Kober, Alexis Jacquier, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs)Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, et al.
International Journal of Cardiology|October 23, 2012
Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapyThomas Cuisset, Bénédicte Gaborit, Noémie Dubois, et al.
The American Journal of Cardiology|October 9, 2012
Prasugrel monitoring and bleeding in real world patientsGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
JACC. Cardiovascular Interventions|December 22, 2012
CYP2C19*2 and *17 alleles have a significant impact on platelet response and bleeding risk in patients treated with prasugrel after acute coronary syndromeThomas Cuisset, Marie Loosveld, Pierre Emmanuel Morange, et al.
The American Journal of Cardiology|November 5, 2013
Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stentingMathieu Pankert, Jacques Quilici, Anderson Diendonné Loundou, et al.
Pageof 8